Marmon L, Schidlow D, Palmer J, Balsara R K, Dunn J M
J Pediatr Surg. 1983 Dec;18(6):811-5. doi: 10.1016/s0022-3468(83)80028-1.
Pulmonary sequelae account for a large proportion of the morbidity and mortality of cystic fibrosis. Bronchiectasis, hemoptysis, and abscess formation are often not responsive to conservative medical therapy. Pulmonary resection in selected cystic fibrosis patients is safe and therapeutically rewarding. Eleven pulmonary resections in ten patients with cystic fibrosis were performed. Patients ranged from 2.5 to 19 years of age. Indications for resection were: (1) abscess and bronchiectasis (nine patients), (2) atelectasis and mass (one patient), and (3) life-threatening hemorrhage (one patient). Surgical resection was employed only for medically refractory lesions which were life-threatening or contaminated otherwise functional lungs. Resection was limited to the most severely diseased areas, sparing functional lung parenchyma when possible. In this series, 9 lobectomies, 1 pneumonectomy, and 1 segmentectomy were performed. Preoperative management included aggressive chest physiotherapy and postural drainage, rigid bronchoscopic lavage, and broad-spectrum parenteral antibiotics. All patients were extubated in the operating room immediately postoperatively. Tracheostomy was not employed. There were no perioperative complications. All patients experienced subjective improvement. Objectively, improvement following surgical resection included: decreased cough and sputum production, and decreased incidence of exacerbations of pulmonary infections. Limited pulmonary resection when combined with intensive preoperative pulmonary toilet is a safe adjunct in the treatment of bronchiectasis and hemoptysis secondary to cystic fibrosis. Pulmonary resection should be limited to only severely destroyed lung parenchyma which is refractory to medical management. In contradistinction to other authors we have not found tracheostomy a necessary adjunct in surgical management.
肺部后遗症在囊性纤维化的发病率和死亡率中占很大比例。支气管扩张、咯血和脓肿形成通常对保守药物治疗无反应。对选定的囊性纤维化患者进行肺切除是安全且具有治疗价值的。对10例囊性纤维化患者进行了11次肺切除。患者年龄在2.5岁至19岁之间。切除的指征为:(1)脓肿和支气管扩张(9例患者),(2)肺不张和肿块(1例患者),以及(3)危及生命的出血(1例患者)。手术切除仅用于药物治疗无效、危及生命或已感染但功能尚存的肺部病变。切除仅限于病变最严重的区域,尽可能保留有功能的肺实质。在本系列中,进行了9次肺叶切除术、1次全肺切除术和1次肺段切除术。术前管理包括积极的胸部物理治疗和体位引流、硬质支气管镜灌洗以及广谱肠外抗生素治疗。所有患者术后均在手术室立即拔除气管插管。未行气管造口术。无围手术期并发症。所有患者主观症状均有改善。客观上,手术切除后的改善包括:咳嗽和咳痰减少,肺部感染加重的发生率降低。有限的肺切除结合强化的术前肺部清洁措施是治疗囊性纤维化继发支气管扩张和咯血的安全辅助手段。肺切除应仅限于药物治疗无效的严重受损肺实质。与其他作者不同的是,我们未发现气管造口术是手术管理中的必要辅助手段。